Therapix Biosciences Ltd.'s CFO Josh Blacher agreed to step down under a mutually amicable separation agreement, effective Dec. 19.
Blacher was appointed Therapix Biosciences' CFO in May 2017.
The company said it was searching for a new CFO and Blacher will support an orderly transition of his overall responsibilities to his replacement.
